MitraClip
Did you know that mitral regurgitation or the improper closure of the mitral valve is the most common valvular disease worldwide whose prevalence increases with age?
Mitral regurgitation affects 2% of the total world’s population and is classified into primary and secondary mitral valve disease.
There are various causes of mitral valve disease including structural deformity within the heart, congenital (by birth) defects, degenerative changes in the valve, or rheumatic fever. If left untreated, mitral regurgitation can lead to congestive heart failure or even death.
Luckily, the invention of MitraClip, a minimally-invasive, authentic, and clinically-proven procedure used to treat mitral regurgitation has shown a procedural success rate of 86%.
The MitraClip is a small device that is implanted to the patient’s leaky mitral valve to help the valve close properly and ensure proper flow of blood through the heart and rest of the body.
MitraClip is used to treat both primary (degenerative) mitral regurgitation and secondary (functional) mitral valve regurgitation.
Over 100,000 people worldwide with MitraClip implantation reported a continued improvement in their quality of life and health after undergoing the treatment.
Another major advantage of MitraClip procedure is that it is done without requiring an open heart surgery or temporarily stopping the heart for support with a heart-lung machine.
The procedure is performed while the patient’s heart is functioning, reducing the risks of heart failure.
The other benefits of MitraClip therapy includes shorter hospital stay and faster recovery time compared to surgical procedures with 16+ years of proven patient safety and experience.
MitraClip Success Rates
FAQ's
What are the indications of MitraClip implantation?
Patients with moderate to severe (3+ grade) symptomatic mitral regurgitation who are at a risk for open heart mitral valve surgery are eligible for the procedure and may be evaluated for MitraClip implantation.
What is the average cost of MitraClip therapy?
Is mitral valve replacement and mitral valve repair the same procedure?
Mitral valve replacement and mitral valve repair are not the same procedure. Both therapies are used to fix a leaky mitral valve to ensure proper blood flow, but follow a different technique.
As the name indicates, mitral valve replacement removes the damaged valve and replaces it with an artificial healthy valve.
But the mitral valve repair implants a healthy valve without removing the leaky mitral valve. An example of the mitral valve repair is the MitraClip implantation therapy that clips the leaky valve with a healthy MitraClip.
What are the major symptoms that may indicate mitral valve disease?
The major symptoms that indicate mitral valve disease include shortness of breath, irregular or rapid heartbeat, and severe fatigue. However, the diagnosis of mitral valve regurgitation is confirmed through diagnostic tests, like cardiac MRI or CT-scan.
What is the success rate of MitraClip implantation therapy?
With timely treatment and proper selection of the right candidate for MitraClip implantation, the average success rate of the therapy is approximately 95%.
Moreover, 90% of patients don’t require reoperation after MitraClip treatment for around 20 years.